These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 27855963)

  • 1. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
    Sanchez K; Page D; McArthur HL
    Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
    Hu ZI; Ho AY; McArthur HL
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Blockade in Breast Cancer Therapy.
    Bu X; Yao Y; Li X
    Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.
    Emens LA
    Expert Rev Anticancer Ther; 2012 Dec; 12(12):1597-611. PubMed ID: 23253225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in Vaccine Therapies for Breast Cancer.
    Li X; Bu X
    Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for the treatment of breast cancer.
    Ernst B; Anderson KS
    Curr Oncol Rep; 2015 Feb; 17(2):5. PubMed ID: 25677118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of immunotherapy in breast cancer?
    Tan TJ; Chan JJ; Kamis S; Dent RA
    Chin Clin Oncol; 2018 Apr; 7(2):13. PubMed ID: 29764158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in Breast Cancer.
    Marmé F
    Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.
    Ravelli A; Reuben JM; Lanza F; Anfossi S; Cappelletti MR; Zanotti L; Gobbi A; Milani M; Spada D; Pedrazzoli P; Martino M; Bottini A; Generali D;
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):689-702. PubMed ID: 25927868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
    Spigel DR; Socinski MA
    J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for the treatment of breast cancer.
    Moreno Ayala MA; Gottardo MF; Asad AS; Zuccato C; Nicola A; Seilicovich A; Candolfi M
    Expert Opin Biol Ther; 2017 Jul; 17(7):797-812. PubMed ID: 28446053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of checkpoint inhibition in localized bladder cancer.
    Singh P; Black P
    Urol Oncol; 2016 Dec; 34(12):548-555. PubMed ID: 27776977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic options on the horizon in breast cancer treatment.
    van Rooijen JM; Stutvoet TS; Schröder CP; de Vries EG
    Pharmacol Ther; 2015 Dec; 156():90-101. PubMed ID: 26388292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of breast cancer.
    Wright SE
    Expert Opin Biol Ther; 2012 Apr; 12(4):479-90. PubMed ID: 22413825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Blockade Inhibition in Breast Cancer.
    Voutsadakis IA
    Anticancer Res; 2016 Nov; 36(11):5607-5622. PubMed ID: 27793883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Immunotherapy Strategies in Breast Cancer.
    Yu LY; Tang J; Zhang CM; Zeng WJ; Yan H; Li MP; Chen XP
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading.
    Force J; Leal JHS; McArthur HL
    Curr Treat Options Oncol; 2019 Mar; 20(4):35. PubMed ID: 30923913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.